Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjiv (HUF)27-08-2017
27-08-2017
Notice Of AGM, Annual Report For 2016-17 And Remote E-Voting Instructions
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of the Annual Report for the financial year ended on 31.03.2017 (containing notice of 22nd Annual General Meeting, Standalone financial statements, Directors and Auditors Reports thereon and Corporate Governance Report, Management Discussion and Analysis Report and consolidated...26-08-2017
Fixes Book Closure for Final Dividend & AGM
Nectar Lifesciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2017 to September 28, 2017 (both days inclusive) for the purpose of Payment of Final Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on September 28, 2017.16-08-2017
Book Closure For AGM And Dividend.
Register of Members and Share Transfer Books will remain closed from 22nd September, 2017 to 28th September 2017 (Both days inclusive) for the purpose of Annual General Meeting (AGM) and dividend, if any, declared by member in the AGM. Accordingly the cut of date, to ascertain the eligibility of members for remote e-voting and polling at AGM, is September 21, 2017 i.e. the date prior to the commencement of book closure.12-08-2017
Financial Results For The Quarter Ended June 30, 2017
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone Financial results for the quarter ended June 30, 2017 which are enclosed herewith along with the Limited Review Report of the Auditors thereon. This is for your information and record.12-08-2017
Notice Of Board Meeting To Be Held On Saturday, August 12, 2017 And Notice Of Trading Window
We wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday August 12, 2017 to consider and approve, inter alia amongst items: 1. The Unaudited Financial Results of the Company for the Quarter ended on June 30, 2017. 2. To convene the Annual General Meeting of Members of the Company for the financial year 2016-17 and matters related thereto....04-08-2017
Shareholding for the Period Ended June 30, 2017
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here06-07-2017
Statement Of Investor Complaints For The Quarter Ended On June 30, 2017
Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statement of Investor Complaints for the Quarter ended June 30, 2017 is attached.05-07-2017
Board recommends Final Dividend
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 27, 2017, inter alia, have recommended the 5% Final Dividend i.e. Re. 0.05/- per equity share to the members of the company, out of profits of the company for the financial year 2016-2017, subject to the approval of the members in their Annual General Meeting.27-06-2017